Sugi Predict

Sugi Predict / Compounds / SCHEMBL6735451

SCHEMBL6735451

SCHEMBL6735451

CS(=O)(=O)c1cc(F)c(-c2nc(C(F)(F)F)[nH]c2-c2ccc(F)c(F)c2)cc1F

nearest known ligand 0.38

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 5/20 0.38
▸ ALOX5AP P20292 2/20 0.38
▸ FEN1 P39748 2/20 0.38
▸ ESR1 P03372 1/20 0.37
▸ ESR2 Q92731 1/20 0.37
▸ NR1H2 P55055 3/20 0.36
▸ NR1H3 Q13133 3/20 0.36
▸ ALOX5 P09917 1/20 0.35
▸ MAPK14 Q16539 5/20 0.35
▸ BRAF P15056 2/20 0.34
▸ KIF11 P52732 1/20 0.34
▸ PTGS1 P23219 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6733585 0.91 PTGS2 (0.42) PTGS2ALOX5APFEN1ESR1ESR2
SCHEMBL6733540 0.90 ESR1 (0.39) PTGS2ALOX5APFEN1ESR1ESR2
SCHEMBL6729150 0.90 PTGS2 (0.42) PTGS2ALOX5APFEN1ESR1ESR2
SCHEMBL6734677 0.90 BRAF (0.44) PTGS2ESR1ESR2ALOX5MAPK14
SCHEMBL6737168 0.89 PTGS2 (0.42) PTGS2ALOX5APFEN1ESR1ESR2
SCHEMBL6736539 0.89 ALOX5AP (0.42) PTGS2ALOX5APFEN1ESR1ESR2
SCHEMBL6736814 0.89 PTGS2 (0.40) PTGS2ALOX5APFEN1ESR1ESR2
SCHEMBL6728472 0.89 PTGS2 (0.45) PTGS2ALOX5APFEN1ESR1ESR2
SCHEMBL6733692 0.88 SCN9A (0.38) PTGS2ALOX5APFEN1ESR1ESR2
SCHEMBL6733102 0.88 ESR1 (0.35) PTGS2ALOX5APFEN1ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6699884-B2 ANTIINFLAMMATORY CYCLOOXYGENASE INHIBITORS. PHARMACIA CORPORATION 2004-03-02 — — US claimed
US-20040138261-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2004-07-15 — — US disclosed
US-6699884-B2 ANTIINFLAMMATORY CYCLOOXYGENASE INHIBITORS. PHARMACIA CORPORATION 2004-03-02 — — US disclosed
US-6673818-B2 TREATING CYCLOOXYGENASE-2 MEDIATED DISORDERS, SUCH AS ARTHRITIS, PAIN, FEVER AND CANCER PHARMACIA CORPORATION 2004-01-06 — — US disclosed
US-20030149078-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2003-08-07 — — US disclosed
US-20030032657-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2003-02-13 — — US disclosed
EP-1251126-A2 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation Pharmacia Corporation (US) 2002-10-23 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138261-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation FPR1, FPR2, FPR3 PTGS2 10/4885ALOX5AP 603/4885FEN1 1023/4885
US-20030149078-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation FPR1, FPR2, FPR3 PTGS2 10/4885ALOX5AP 603/4885FEN1 1023/4885
US-20030032657-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation FPR1, FPR2, FPR3 PTGS2 10/4885ALOX5AP 603/4885FEN1 1023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.